Canbridge Life Sciences LTD
1Patents
1Active
1Granted
38Portfolio score
Filing activity: Jun 12, 2018 → Jun 12, 2018
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US11834716B2 | Method for predicting response of esophagus cancer to anti-ERBB3 antibody therapy, and kit | Physics | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.